AGMB — AGOMAB THERAPEUTICS NV
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying AGMB?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their AGMB position last quarter, 2 bought and 0 sold (100% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +2 tracked investors added or increased positions last quarter (Steve Cohen, Ken Griffin)
- +2 tracked investors reported holding AGMB at their latest filing
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About AGOMAB THERAPEUTICS NV (AGMB)
AGOMAB THERAPEUTICS NV (AGMB) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $998,994. Across recent filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AGMB
How many top investors track AGMB
Only 2 tracked investors report this position.
AGMB Ownership Composition
How AGOMAB THERAPEUTICS NV is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting AGMB
1 tracked investor has since exited this position — listed separately below.
- Steve CohenSep 30, 2026Point72 Asset ManagementShares67KValue$744.1K% Portfolio0.00%
- Ken GriffinSep 30, 2026Citadel AdvisorsShares11.6KValue$129.1K% Portfolio0.00%
Previously held AGMB
These investors reported AGMB in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Izzy Englander | Millennium Management | 95.2K | $999K | Mar 31, 2026 |
Recent activity
- New$744.1KNov 16, 2026
- New$129.1KNov 16, 2026
- $999KMay 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- Sold$0(-100.00%)Aug 14, 2026
Frequently asked questions
- How many institutional investors hold AGMB?
- 2 tracked institutional investors disclosed a position in AGMB (AGOMAB THERAPEUTICS NV) in their most recent 13F filing.
- Who is the largest institutional holder of AGMB?
- Izzy Englander, Millennium Management, holds the largest disclosed position in AGMB, valued at $998,994.
- Did institutional ownership of AGMB increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 2 fully exited AGMB.
- Where does this AGMB ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.